Posts Tagged ‘Matthew Sherwood’
New study shows AI alerts help more heart patients get life-saving valve disease care
A major new national study led by Inova cardiologist Wayne Batchelor, MD, MHS, MBA, shows that artificial intelligence (AI) can help doctors find and treat serious heart valve disease sooner – especially for patients who are frequently undertreated, despite availability of effective valve therapies. Dr. Batchelor, an interventional cardiologist and President of Inova’s Medicine Service…
Read MoreInova introduces minimally invasive tricuspid valve replacement to the region
Inova’s Structural Heart and Valve Disease Program is among the region’s first to offer transcatheter tricuspid valve replacement (TTVR). This exciting milestone expands the range of minimally invasive cardiac procedures available at Inova to now include not only tricuspid valve repair but also replacement of the valve. “This is the first replacement technology alternative to…
Read MoreInova Heart and Vascular Institute Recruiting Patients for AFib Stroke Prevention Device Clinical Trial
Matthew W. Sherwood, MD, MHS, is an Inova interventional cardiologist, Director of Inova’s Left Atrial Appendage Closure/WATCHMAN Program and Co-Director of Inova’s Structural Heart Disease Program. Dr. Sherwood is board-certified in interventional cardiology, cardiovascular disease and internal medicine. Millions of Americans have atrial fibrillation (AFib) and take oral anticoagulant medication (blood thinners) every day. These…
Read MoreWhat is AFib? A Guide to Atrial Fibrillations Symptoms & Treatments
Matthew W. Sherwood, MD, MHS, is board-certified in interventional cardiology, cardiovascular disease and internal medicine. Marc H. Wish, MD, is board-certified in clinical cardiac electrophysiology and cardiovascular disease. Dr. Sherwood and Dr. Wish practice at the Inova Heart and Vascular. Atrial fibrillation — commonly called AFib — is a heart rhythm problem that causes an…
Read MoreInova Heart Team Tests New, Minimally Invasive Option to Replace Leaky Mitral Valves
Matthew W. Sherwood, MD, MHS, is board certified in interventional cardiology, cardiovascular disease and internal medicine. He practices at the Inova Schar Heart and Vascular. The Inova Schar Heart and Vascular has a long history as a leader in treating heart disease. True to that mission, we’re excited to offer an innovative new treatment for patients…
Read MoreThe GALILEO Trial: Inova Researchers Study New Drug Therapy for Heart Patients
Matthew W. Sherwood, MD, is board certified in interventional cardiology, cardiovascular disease and internal medicine. He practices at the Inova Schar Heart and Vascular. Read Dr. Sherwood’s profile. Starting in March, we began enrolling patients in a first-of-its-kind study to compare drug therapies for patients who have had transcatheter aortic valve replacement, or TAVR. As…
Read More